Durvalumab-680LT
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Durvalumab-680LT, covering 2025-11-21 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Quantitative Fluorescence Endoscopy Using Durvalumab-680LT in Esophageal Cancer [Phase 1]